Application of an iPSC-Derived Organoid Model for Localized Scleroderma Therapy. [PDF]
Ma J +16 more
europepmc +1 more source
Objective: Biologic drugs are a potential treatment option in resistant cases of juvenile scleroderma. In this review, we aimed to examine previous studies regarding biologic drug use in pediatric patients with localized scleroderma and systemic ...
BATU AKAL, EZGİ DENİZ, Sener, Seher
core +1 more source
Evans' syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma. [PDF]
Gambichler T +3 more
europepmc +1 more source
JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review. [PDF]
Zheng R, Zou L, Li SC, Lu M.
europepmc +1 more source
Localized scleroderma with pulmonary arterial hypertension and pulmonary interstitial fibrosis in a patient with positive Th/to antibodies: Case report and review of literature. [PDF]
Elinkichari D +6 more
europepmc +1 more source
Parry-Romberg Syndrome With Localized Scleroderma: A Report of Two Pediatric Cases From Oman. [PDF]
Al Lawati MH +4 more
europepmc +1 more source
Familial localized scleroderma with paediatric onset: a review. [PDF]
Yurtsever I +5 more
europepmc +1 more source
Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]
Şener S +4 more
europepmc +1 more source
Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study. [PDF]
Wang HC +5 more
europepmc +1 more source
A case of early localized scleroderma that was manifested as a port-wine stain. [PDF]
Meng Q, Guo M, Yuan D, Deng H.
europepmc +1 more source

